BIENAIME JEAN JACQUES bought IMNM
March 11, 2026 · Form 4 insider transaction
BIENAIME JEAN JACQUES bought 1,000 shares of Immunome, Inc. at $21.55 per share, a transaction worth $21.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,000
Price
$21.55
Total value
$21.6K
InsiderBIENAIME JEAN JACQUES
RoleDirector
CompanyImmunome, Inc. (IMNM)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 11, 2026
Filing dateMarch 12, 2026
Shares owned after38,415
OwnershipDirect
10b5-1 planNo
AmendedNo